Oncternal Therapeutics ONCT reported its Q1 earnings results on Thursday, May 4, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Oncternal Therapeutics reported in-line EPS of $-0.2 versus an estimate of $-0.2.
Revenue was down $543 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 15.37% drop in the share price the next day.
Here's a look at Oncternal Therapeutics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -0.24 | -0.23 | -0.2 |
| EPS Actual | -0.20 | -0.21 | -0.23 | -0.2 |
| Revenue Estimate | 330K | 310K | 460K | 520K |
| Revenue Actual | 171K | 382K | 191K | 746K |
To track all earnings releases for Oncternal Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: EarningsBZI-Recaps